Volume 46, no. 6, p. 1887-1895, 2002. Page 1889, column 1, line 13 from bottom: “IMiD3 (α-3-aminophthalimido-glutarimide)” should read “IMiD3 [3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione].”
. 2002 Jul;46(7):2313. doi: 10.1128/AAC.46.7.2313.2002
Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis
Liana Tsenova
1, Bande Mangaliso
1, George Muller
1, Yong Chen
1, Victoria H Freedman
1, David Stirling
1, Gilla Kaplan
1
Liana Tsenova
1Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021, and Celgene Corporation, Warren, New Jersey 07059
Find articles by Liana Tsenova
Bande Mangaliso
1Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021, and Celgene Corporation, Warren, New Jersey 07059
Find articles by Bande Mangaliso
George Muller
1Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021, and Celgene Corporation, Warren, New Jersey 07059
Find articles by George Muller
Yong Chen
1Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021, and Celgene Corporation, Warren, New Jersey 07059
Find articles by Yong Chen
Victoria H Freedman
1Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021, and Celgene Corporation, Warren, New Jersey 07059
Find articles by Victoria H Freedman
David Stirling
1Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021, and Celgene Corporation, Warren, New Jersey 07059
Find articles by David Stirling
Gilla Kaplan
1Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021, and Celgene Corporation, Warren, New Jersey 07059
Find articles by Gilla Kaplan
1Laboratory of Cellular Physiology and Immunology, The Rockefeller University, New York, New York 10021, and Celgene Corporation, Warren, New Jersey 07059
Copyright © 2002, American Society for Microbiology
PMCID: PMC127321
This corrects the article "Use of IMiD3, a Thalidomide Analog, as an Adjunct to Therapy for Experimental Tuberculous Meningitis" on page 1887.